Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Nuclear Medicine/Radiopharmaceuticals MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2025

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

This report studies the global Nuclear Medicine/Radiopharmaceuticals market, analyzes and researches the Nuclear Medicine/Radiopharmaceuticals development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
IBA Molecular Imaging

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Nuclear Medicine/Radiopharmaceuticals can be split into
Diagnostic (SPECT - Technetium, PET - F-18)
Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)

Market segment by Application, Nuclear Medicine/Radiopharmaceuticals can be split into
Oncology
Thyroid
Cardiology

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

Global Nuclear Medicine/Radiopharmaceuticals Market Size, Status and Forecast 2025
1 Industry Overview of Nuclear Medicine/Radiopharmaceuticals
1.1 Nuclear Medicine/Radiopharmaceuticals Market Overview
1.1.1 Nuclear Medicine/Radiopharmaceuticals Product Scope
1.1.2 Market Status and Outlook
1.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Nuclear Medicine/Radiopharmaceuticals Market by Type
1.3.1 Diagnostic (SPECT - Technetium, PET - F-18)
1.3.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
1.4 Nuclear Medicine/Radiopharmaceuticals Market by End Users/Application
1.4.1 Oncology
1.4.2 Thyroid
1.4.3 Cardiology

2 Global Nuclear Medicine/Radiopharmaceuticals Competition Analysis by Players
2.1 Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Cardinal Health
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Mallinckrodt
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 GE Healthcare
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Lantheus Medical Imaging
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Bayer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Bracco Imaging
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Eczacibasi-Monrol Nuclear Products
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Nordion
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Advanced Accelerator Applications
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 IBA Molecular Imaging
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2014-2019)
3.10.5 Recent Developments

4 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type and Application (2014-2019)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2014-2019)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2014-2019)
4.3 Potential Application of Nuclear Medicine/Radiopharmaceuticals in Future
4.4 Top Consumer/End Users of Nuclear Medicine/Radiopharmaceuticals

5 United States Nuclear Medicine/Radiopharmaceuticals Development Status and Outlook
5.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size (2014-2019)
5.2 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2018 and 2019)

6 EU Nuclear Medicine/Radiopharmaceuticals Development Status and Outlook
6.1 EU Nuclear Medicine/Radiopharmaceuticals Market Size (2014-2019)
6.2 EU Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2018 and 2019)

7 Japan Nuclear Medicine/Radiopharmaceuticals Development Status and Outlook
7.1 Japan Nuclear Medicine/Radiopharmaceuticals Market Size (2014-2019)
7.2 Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2018 and 2019)

8 China Nuclear Medicine/Radiopharmaceuticals Development Status and Outlook
8.1 China Nuclear Medicine/Radiopharmaceuticals Market Size (2014-2019)
8.2 China Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2018 and 2019)

9 India Nuclear Medicine/Radiopharmaceuticals Development Status and Outlook
9.1 India Nuclear Medicine/Radiopharmaceuticals Market Size (2014-2019)
9.2 India Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2018 and 2019)

10 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Development Status and Outlook
10.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (2014-2019)
10.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2018 and 2019)

11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Regions (2019-2025)
11.1.1 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2019-2025)
11.1.2 EU Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2019-2025)
11.1.3 Japan Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2019-2025)
11.1.4 China Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2019-2025)
11.1.5 India Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2019-2025)
11.1.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2019-2025)
11.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Type (2019-2025)
11.3 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2019-2025)

12 Nuclear Medicine/Radiopharmaceuticals Market Dynamics
12.1 Nuclear Medicine/Radiopharmaceuticals Market Opportunities
12.2 Nuclear Medicine/Radiopharmaceuticals Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Nuclear Medicine/Radiopharmaceuticals Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Nuclear Medicine/Radiopharmaceuticals Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us